Dr. AquinoAug 8, 20214 minPilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
Dr. AquinoAug 7, 20211 minLow-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy